News & Press Releases

Capricorn’s latest publication Protective efficacy of the UniFluVec influenza vaccine vector against the highly pathogenic influenza A/Indonesia/5/2005 (H5N1) strain in ferrets on the UniFluVec™ platform’s protective efficacy against the highly pathogenic H5N1 influenza virus in ferrets.… Read more: UniFluVec™ is protective against the pathogenic H5N1 virus

We are pleased to highlight a significant new publication from Capricorn, entitled UniFluVec influenza vector induces heterosubtypic protection in ferrets after intranasal administration despite high attenuation.  This study explores the potential of the UniFluVec™ platform to… Read more: UniFluVec™ platform confers protection different subtypes of influenza virus

Capricorn Technologies, together with its subsidiary NuCell GmbH (Tulln, Austria), has reached a significant milestone in the development of its new patented AEX-1 cells—an advanced Vero-derived cell line engineered for… Read more: Press release. Capricorn Technologies’ Subsidiary NuCell GmbH Achieve Milestone with Novel AEX-1 Cell Line for Superior Virus Production

Capricorn Technologies GmbH has taken the next step in its development. By founding NuCell GmbH, it has expanded its research portfolio with a groundbreaking new product: AEX-1. The AEX-1 cell… Read more: Capricorn Incorporates a New Company: NuCell GmbH (Austria)